Indaptus Therapeutics, Inc.
INDP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,975 | -$5,229 | -$4,532 | -$4,131 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $181 | $241 | $304 |
| Change in WC | -$135 | $242 | -$756 | $431 |
| Other Non-Cash | $55 | $788 | $0 | $0 |
| Operating Cash Flow | -$3,055 | -$4,018 | -$5,047 | -$3,396 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $233 | $5,742 | $0 | $0 |
| Stock Issued | $2,489 | $588 | $3,151 | $2,135 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$45 | $0 | -$333 |
| Financing Cash Flow | $2,723 | $6,285 | $3,151 | $1,802 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$332 | $2,267 | -$1,896 | -$1,594 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,158 | $3,891 | $5,787 | $7,381 |
| End Cash | $5,826 | $6,158 | $3,891 | $5,787 |
| Free Cash Flow | -$3,055 | -$4,018 | -$5,047 | -$3,396 |